Boostrix is used for preventing tetanus, diphtheria, and pertussis. This "booster" vaccine is approved for adults and children as young as 10 years old. It was formulated after healthcare providers determined that the childhood DTaP series does not provide sufficient protection from pertussis throughout adolescence and adulthood. There are currently no off-label uses.
What Is Boostrix Used For?Boostrix® (Tdap vaccine) is a "booster" vaccine used for the prevention of tetanus, diphtheria, and pertussis (whooping cough) in adolescents and adults.
In the past, the pertussis vaccine was only given to children as part of the DTaP series. Adults and adolescents received boosters of just the diphtheria and tetanus components as the Td vaccine. However, healthcare providers began noticing that pertussis seemed to be on the rise in adults and adolescents who had been vaccinated as children and should have been protected from the disease. It is now known that the childhood DTaP series does not provide sufficient protection from pertussis throughout adolescence and adulthood.
As a result, Boostrix was developed in order to provide a booster of additional protection from pertussis. It is given as just a single dose for most people, except for pregnant women, who should receive a dose with each pregnancy, even if they have had the vaccine before.
After receiving this vaccine, the standard Td vaccine (which was given in the past) is recommended once every 10 years, just as was previously recommended.
Because pertussis is especially dangerous for newborns and young infants, Boostrix is especially important for new parents or others who will be in contact with young infants. In fact, it is recommended that mothers who have not received the DTaP vaccine be vaccinated as soon as possible after childbirth -- usually while still in the hospital.